1-6 of 6
David Inwards
Close
Sort by
Journal Articles

Acalabrutinib for mantle cell lymphoma

Thomas E. Witzig, David Inwards
Journal: Blood
Blood (2019) 133 (24): 2570–2574.
https://doi.org/10.1182/blood.2019852368
Published: 2019
Journal Articles

Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience

Clinical Trials & Observations
Anita D'Souza, Martha Lacy, Morie Gertz, Shaji Kumar, Francis Buadi, Suzanne Hayman, David Dingli, Steven Zeldenrust, Robert Kyle, Stephen Ansell, David Inwards, Patrick Johnston, Ivana Micallef, Luis Porrata, Mark Litzow, Dennis Gastineau, William Hogan, Angela Dispenzieri
Journal: Blood
Blood (2012) 120 (1): 56–62.
https://doi.org/10.1182/blood-2012-04-423178
Published: 2012
Journal Articles

Predicting Poor Peripheral Blood Stem Cell Mobilization Using Initial Peripheral CD34 Counts in Patients with Lymphoma.

Shirshendu Sinha, MBBS, Shaji Kumar, MD, Dennis A. Gastineau, MD, William Hogan, MD, Francis Buadi, MD, David Dingli, PhD., M.D., Angela Dispenzieri, MD, Morie A Gertz, MD, Carl Greiner, Suzzane Hayman, MD, David Inwards, MD, Patrick B Johnston, MD, PhD, Martha Q. Lacy, MD, Mark R. Litzow, MD, Luis F. Porrata, MD, Jeffrey Winters, MD, Ivana N Micallef, MD
Journal: Blood
Blood (2009) 114 (22): 4228.
https://doi.org/10.1182/blood.V114.22.4228.4228
Published: 2009
Journal Articles

90 Y Ibritumomab Tiuxetan (Zevalin®; 90 YZ) Doses Calculated To Deliver up to 1500 cGy to Critical Organs May Be Safely Combined with High-Dose BEAM and Autotransplant in NHL.

Jane N. Winter, MD, David Inwards, M.D., Stewart Spies, M.D., Gregory Wiseman, M.D., David Patton, B.S., William Erwin, M.S., Alfred Rademaker, Ph.D., Stephanie Williams, M.D., Martin S. Tallman, M.D., Ivana Micallef, M.D., Jayesh Mehta, M.D., Seema Singhal, M.D., Andrew Evens, D.O., Michael Zimmer, Ph.D., Arturo Molina, M.D., Christine White, M.D., Leo I. Gordon, M.D.
Journal: Blood
Blood (2006) 108 (11): 330.
https://doi.org/10.1182/blood.V108.11.330.330
Published: 2006
Journal Articles

Autologous Stem Cell Transplantation for Multiple Myeloma in Patients over 70 Years: A Matched Comparison with Patients under 65 Years.

Shaji Kumar, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Suzzane Hayman, MD, William Hogan, MD, Luis Poratta, MD, Michelle Elliot, MD, Stephen Ansell, MD, Patrick Johnston, MD, Ivana Micallef, MD, David Inwards, MD, Dennis Gastineau, MD, Mark Litzow, MD, Morie Gertz, MD
Journal: Blood
Blood (2005) 106 (11): 1173.
https://doi.org/10.1182/blood.V106.11.1173.1173
Published: 2005
Journal Articles

Anti-Tumor Activity of Single-Agent CCI-779 for Relapsed Mantle Cell Lymphoma: A Phase II Trial in the North Central Cancer Treatment Group.

Thomas Witzig, M.D., Susan Geyer, Ph.D., Irene Ghobrial, M.D., David Inwards, M.D., Rafael Fonseca, M.D., Scott Kaufmann, M.D., Ph.D., Paul Kurtin, M.D., Joseph Colgan, M.D., William Morice, M.D., Ph.D., Steven Alberts, M.D., Muhammed Salim, M.D., Kendrith Rowland, M.D., Shaker Dakhil, M.D., Roscoe Morton, M.D., Philip Stella, M.D.
Journal: Blood
Blood (2004) 104 (11): 129.
https://doi.org/10.1182/blood.V104.11.129.129
Published: 2004